Gene Therapy for Rare Disorders Europe 2017

Gene Therapy for Rare Disorders Europe is devoted to overcoming these challenges, focusing specifically on the clinical, manufacturing, regulatory and reimbursement hurdles that need to be overcome for gene therapies to reach their full potential. Uniting leaders from Pfizer, GSK, Shire and uniQure, this meeting focusses specifically on delivering practical insights into developing the next generation of gene therapies that promise improved efficacy, enhanced safety and commercial viability. Join your colleagues at this uniquely focused event and discover how to enhance every stage of your gene therapy development to achieve commercial success. Prices do not include VAT. Email [email protected] for an Academic rate.